In the News | Charles River
   
 
 
   
   

Q&A: CROs adjust to changing pipeline priorities
R&D Directions – October 2009

A corporate senior VP of Charles River Laboratories recently talked with R&D Directions managing editor Michael Christel about the trend in big pharma of companies reprioritizing and consolidating their R&D portfolios, and how those changes are affecting decisions by contract research organizations to invest in certain therapeutic areas...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
Mar 02 - BioPharm International: Meeting Ch...
Feb 13 - Fourth-Quarter and Full-Year 2011 ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Manager International Tax Wilmington, MA
Scientist I Wilmington, MA

Charles River Laboratories, Inc.